The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma.

Daniel Puhr-WesterheideClemens C CyranJosef Sargsyan-BergmannAndrei TodicaFranz-Josef GildehausWolfgang G KunzRobert StahlChristine SpitzwegJens RickePhilipp M Kazmierczak

Published in: Cancer imaging : the official publication of the International Cancer Imaging Society (2019)

Gadoxetic acid-enhanced MRI allows for a more precise liver staging in MTC patients compared to 18F-DOPA-PET/CT alone, particularly for 18F-DOPA-negative metastases and lesions < 1 cm.

Keyphrases

pet ct
diffusion weighted imaging
positron emission tomography
end stage renal disease
magnetic resonance imaging
contrast enhanced
ejection fraction
chronic kidney disease
newly diagnosed
computed tomography
magnetic resonance